Impact of Anxiety on Quality of Life in Parkinson's Disease
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve the patient's quality of life. Many studies focus on the impact of depression and motor disability on poor life quality but neglect to examine the role of anxiety. We investigated the impact of anxiety and depression on health-related quality of life in PD, using the Parkinson's Disease Quality of Life measure (PDQ-39). Symptoms of anxiety, more than depression, cognitive status, or motor stage, significantly affected quality of life in 38 nondemented patients with mild-to-moderate motor disability. Stepwise regression analyses revealed that anxiety explained 29% of the variance in the PDQ-39 sum score, and depression explained 10% of the variance beyond that accounted for by anxiety. The findings suggest that primary management of anxiety as well as depression may be important to optimizing the quality of life of PD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Sheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
Peto, V., Jenkinson, C., Fitzpatrick, R., & Greenhall, R. (1995) · Quality of Life Research · doi:10.1007/bf02260863 · Cited by 1,204 · cited 2×
“The PDQ39 is the most widely used disease-specific health status questionnaire in the literature and has demonstrated high reliability and validity in PD [33].”
BackgroundMethodLyness, J. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440250107012 · Cited by 484 · cited 1×
“Clinically significant depression was present in eight (21%) when determined by the BDI-II with a highly specific cut-off score of 17 [16] and in 17 (45%) when measured by the GDS with a standard cut-off score of 10, which has yielded 100% sensitivity and 84% specificity for a diagnosis of major depression in primary…”
MethodThe epidemiology of generalized anxiety disorder
Kessler, R. C., Keller, M. B., & Wittchen, H.-U. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70204-5 · Cited by 337 · cited 1×
“When depression and anxiety occur together, they are associated with increased impairment, a more chronic course, and poorer outcome, rendering treatment more complex [48–50].”
BackgroundPsychological therapies for generalised anxiety disorder
Hunot, V., Churchill, R., Teixeira, V., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001848.pub4 · Cited by 315
Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease
Pontone, G. M., Williams, J. R., Anderson, K. E., Chase, G., Goldstein, S. A., Grill, S., Hirsch, E. S., Lehmann, S., Little, J. T., Margolis, R. L., et al. (2009) · Movement Disorders · doi:10.1002/mds.22611 · Cited by 305 · cited 1×
“The use of a brief self-report measure of anxiety and depression, although practical, does not allow us to clarify the nature of the anxiety and depressive disorder in this population or to determine whether the specific type of anxiety disorder has a differential impact on quality of life—for example, generalized anx…”
BackgroundBELZER, K., & SCHNEIER, F. R. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200409000-00003 · Cited by 235 · cited 1×
“Anxiety symptoms are often comorbid with depression symptoms and the cooccurrence of these disorders is typically characterized by a more chronic course with significant impairment in social and occupational functioning [19].”
BackgroundEvaluation of the Hospital Anxiety and Depression Scale in Patients With Parkinson's Disease
Marinus, J., Leentjens, A. F. G., Visser, M., Stiggelbout, A. M., & van Hilten, J. J. (2002) · Clinical Neuropharmacology · doi:10.1097/00002826-200211000-00008 · Cited by 197 · cited 1×
“Studies have found depression to explain up to 50% of the variance in PDQ-39 scores [1, 3, 5, 38].”
BackgroundHobson, P. (1999) · Age and Ageing · doi:10.1093/ageing/28.4.341 · Cited by 152
Cited by
Does Anxiety Cause Freezing of Gait in Parkinson's Disease?
Ehgoetz Martens, K. A., Ellard, C. G., & Almeida, Q. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106561 · Cited by 171
Anxiety in Parkinson's disease: identification and management
Chen, J. J., & Marsh, L. (2014) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285613495723 · Cited by 161
Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson's disease
Balestrino, R., & Martinez-Martin, P. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.12.060 · Cited by 135
Khedr, E. M., Abdelrahman, A. A., Elserogy, Y., Zaki, A. F., & Gamea, A. (2020) · The Egyptian Journal of Neurology, Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00253-5 · Cited by 61
“Similar studies have demonstrated a correlation between anxiety and QOL in patients with PD [30, 67].”
BackgroundCognitive-Behavioral Therapy for Anxiety in Parkinson’s Disease
Reynolds, G. O., Saint-Hilaire, M., Thomas, C. A., Barlow, D. H., & Cronin-Golomb, A. (2020) · Behavior Modification · doi:10.1177/0145445519838828 · Cited by 59
Self-citationWhat is the lived experience of anxiety for people with Parkinson’s? A phenomenological study
Lovegrove, C. J., & Bannigan, K. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249390 · Cited by 15
Metadata
- Authors
- Hanna, K. K., & Cronin-Golomb, A.
- Venue
- Parkinson's Disease
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-8
- ISSN
- 2042-0080 (ISSN-L)
- 2090-8083
- OpenAlex
- W2031173917
- Cited by
- 89
- References
- 11
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.